Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice

Background: Solid dispersion (SD) has been used conventionally as a successful technique for improving the dissolution profile and bioavailability of poorly water-soluble drugs. The aim of this study was to progress the dissolution rate and bioavailability of naproxen (BCS class II) by SD technique....

Full description

Bibliographic Details
Main Authors: Monia Akter Nupur, Mst Mahfuza Rahman, Khurshida Akter, Khadiza Binte Hanif, Jinat Fatema Sharna, Md Shahin Sarker, Mir Imam Ibne Wahed
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023026397
_version_ 1797815702380347392
author Monia Akter Nupur
Mst Mahfuza Rahman
Khurshida Akter
Khadiza Binte Hanif
Jinat Fatema Sharna
Md Shahin Sarker
Mir Imam Ibne Wahed
author_facet Monia Akter Nupur
Mst Mahfuza Rahman
Khurshida Akter
Khadiza Binte Hanif
Jinat Fatema Sharna
Md Shahin Sarker
Mir Imam Ibne Wahed
author_sort Monia Akter Nupur
collection DOAJ
description Background: Solid dispersion (SD) has been used conventionally as a successful technique for improving the dissolution profile and bioavailability of poorly water-soluble drugs. The aim of this study was to progress the dissolution rate and bioavailability of naproxen (BCS class II) by SD technique. Materials &amp; methods: In this study, hydrophilic carriers are used for preparing solid dispersion of naproxen by evaporation method. The prepared optimized SDNs were evaluated by in-vitro drug dissolution test, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), powder X-ray diffraction (PXRD), and scanning electron microscopy (SEM). The in-vivo analgesic effects tests of the optimized SDNs (SDN-2 and SDN-5) were performed by tail immersion method and writhing method. Results: All the prepared SDNs exhibited a significant increase in the dissolution of naproxen compared to that of the pure drug. Among them, SDN-2 (the dispersion with sodium starch glycolate at 1:2 ratio of naproxen and sodium starch glycolate) and SDN-5 (using the combination of PEG-8000 and sodium starch glycolate with naproxen at 1:1:1 ratio) showed faster dissolution rate as compared to other solid dispersions (SDNs) and pure naproxen. SDN-2 showed 5.4 times better dissolution rate and SDN-5 depicted 6.5-fold increment of dissolution rate compared to pure naproxen drug. DSC, PXRD and SEM microscopy showed that the drugs crystallinity was decreased during the preparation process. FTIR study revealed that naproxen was stable in polymeric dispersions and there was no interaction among the drug and polymers. In writhing method, the percentage inhibition of the number of writhes showed significantly greater (p < 0.01), (p < 0.0001) analgesic activity for the higher dose treatment groups SDN-2(H), and SDN-5(H), respectively, when contrasted to the pure drug naproxen. For tail immersion test, there is increase in latency time at 90 min which is significantly greater (P < 0.01), (P < 0.05), (P < 0.01) for treatment groups SDN-2(H), SDN-5(L), and SDN-5(H), respectively that ultimately authenticates that the optimized SDNs (SDN-2, SDN-5) showed better analgesic activity in mice in comparison with the pure drug. Conclusion: It can be concluded that dissolution of the naproxen could be improved by the making solid dispersion using sodium starch glycolate and/or combination of sodium starch glycolate and PEG 8000 due to the complete transformation of drug into amorphous form with the entire loss of crystallinity, as evidenced by DSC, PXRD, and SEM and also consequences the enhanced analgesic activity in mice.
first_indexed 2024-03-13T08:26:40Z
format Article
id doaj.art-4d841424d9d24bdfbe939bfa529ac4c4
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-13T08:26:40Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-4d841424d9d24bdfbe939bfa529ac4c42023-05-31T04:44:35ZengElsevierHeliyon2405-84402023-05-0195e15432Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in miceMonia Akter Nupur0Mst Mahfuza Rahman1Khurshida Akter2Khadiza Binte Hanif3Jinat Fatema Sharna4Md Shahin Sarker5Mir Imam Ibne Wahed6Department of Pharmacy, Comilla University, Cumilla, 3506, BangladeshDepartment of Pharmacy, Comilla University, Cumilla, 3506, Bangladesh; Corresponding author.Department of Pharmacy, Comilla University, Cumilla, 3506, BangladeshDepartment of Pharmacy, Comilla University, Cumilla, 3506, BangladeshDepartment of Pharmacy, Comilla University, Cumilla, 3506, BangladeshDepartment of Pharmacy, Jashore University of Science &Technology, Jashore, 7408, BangladeshDepartment of Pharmacy, Faculty of Science, University of Rajshahi, Rajshahi, 6205, BangladeshBackground: Solid dispersion (SD) has been used conventionally as a successful technique for improving the dissolution profile and bioavailability of poorly water-soluble drugs. The aim of this study was to progress the dissolution rate and bioavailability of naproxen (BCS class II) by SD technique. Materials &amp; methods: In this study, hydrophilic carriers are used for preparing solid dispersion of naproxen by evaporation method. The prepared optimized SDNs were evaluated by in-vitro drug dissolution test, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), powder X-ray diffraction (PXRD), and scanning electron microscopy (SEM). The in-vivo analgesic effects tests of the optimized SDNs (SDN-2 and SDN-5) were performed by tail immersion method and writhing method. Results: All the prepared SDNs exhibited a significant increase in the dissolution of naproxen compared to that of the pure drug. Among them, SDN-2 (the dispersion with sodium starch glycolate at 1:2 ratio of naproxen and sodium starch glycolate) and SDN-5 (using the combination of PEG-8000 and sodium starch glycolate with naproxen at 1:1:1 ratio) showed faster dissolution rate as compared to other solid dispersions (SDNs) and pure naproxen. SDN-2 showed 5.4 times better dissolution rate and SDN-5 depicted 6.5-fold increment of dissolution rate compared to pure naproxen drug. DSC, PXRD and SEM microscopy showed that the drugs crystallinity was decreased during the preparation process. FTIR study revealed that naproxen was stable in polymeric dispersions and there was no interaction among the drug and polymers. In writhing method, the percentage inhibition of the number of writhes showed significantly greater (p < 0.01), (p < 0.0001) analgesic activity for the higher dose treatment groups SDN-2(H), and SDN-5(H), respectively, when contrasted to the pure drug naproxen. For tail immersion test, there is increase in latency time at 90 min which is significantly greater (P < 0.01), (P < 0.05), (P < 0.01) for treatment groups SDN-2(H), SDN-5(L), and SDN-5(H), respectively that ultimately authenticates that the optimized SDNs (SDN-2, SDN-5) showed better analgesic activity in mice in comparison with the pure drug. Conclusion: It can be concluded that dissolution of the naproxen could be improved by the making solid dispersion using sodium starch glycolate and/or combination of sodium starch glycolate and PEG 8000 due to the complete transformation of drug into amorphous form with the entire loss of crystallinity, as evidenced by DSC, PXRD, and SEM and also consequences the enhanced analgesic activity in mice.http://www.sciencedirect.com/science/article/pii/S2405844023026397NaproxenSolid dispersionPEG 8000Sodium starch glycolateAnalgesic activitysolvent evaporation method
spellingShingle Monia Akter Nupur
Mst Mahfuza Rahman
Khurshida Akter
Khadiza Binte Hanif
Jinat Fatema Sharna
Md Shahin Sarker
Mir Imam Ibne Wahed
Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice
Heliyon
Naproxen
Solid dispersion
PEG 8000
Sodium starch glycolate
Analgesic activity
solvent evaporation method
title Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice
title_full Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice
title_fullStr Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice
title_full_unstemmed Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice
title_short Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice
title_sort preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in vivo evaluation of its analgesic activity in mice
topic Naproxen
Solid dispersion
PEG 8000
Sodium starch glycolate
Analgesic activity
solvent evaporation method
url http://www.sciencedirect.com/science/article/pii/S2405844023026397
work_keys_str_mv AT moniaakternupur preparationandcharacterizationofnaproxensoliddispersionusingdifferenthydrophiliccarriersandinvivoevaluationofitsanalgesicactivityinmice
AT mstmahfuzarahman preparationandcharacterizationofnaproxensoliddispersionusingdifferenthydrophiliccarriersandinvivoevaluationofitsanalgesicactivityinmice
AT khurshidaakter preparationandcharacterizationofnaproxensoliddispersionusingdifferenthydrophiliccarriersandinvivoevaluationofitsanalgesicactivityinmice
AT khadizabintehanif preparationandcharacterizationofnaproxensoliddispersionusingdifferenthydrophiliccarriersandinvivoevaluationofitsanalgesicactivityinmice
AT jinatfatemasharna preparationandcharacterizationofnaproxensoliddispersionusingdifferenthydrophiliccarriersandinvivoevaluationofitsanalgesicactivityinmice
AT mdshahinsarker preparationandcharacterizationofnaproxensoliddispersionusingdifferenthydrophiliccarriersandinvivoevaluationofitsanalgesicactivityinmice
AT mirimamibnewahed preparationandcharacterizationofnaproxensoliddispersionusingdifferenthydrophiliccarriersandinvivoevaluationofitsanalgesicactivityinmice